ES547004A0 - Un procedimiento para preparar hidantoinas opticamente acti-vas - Google Patents

Un procedimiento para preparar hidantoinas opticamente acti-vas

Info

Publication number
ES547004A0
ES547004A0 ES547004A ES547004A ES547004A0 ES 547004 A0 ES547004 A0 ES 547004A0 ES 547004 A ES547004 A ES 547004A ES 547004 A ES547004 A ES 547004A ES 547004 A0 ES547004 A0 ES 547004A0
Authority
ES
Spain
Prior art keywords
hidantoin
vas
preparing
procedure
optically acti
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES547004A
Other languages
English (en)
Other versions
ES8701734A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanegafuchi Chemical Industry Co Ltd
Original Assignee
Kanegafuchi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanegafuchi Chemical Industry Co Ltd filed Critical Kanegafuchi Chemical Industry Co Ltd
Publication of ES547004A0 publication Critical patent/ES547004A0/es
Publication of ES8701734A1 publication Critical patent/ES8701734A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/74Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/006Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
    • C12P41/009Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures by reactions involving hydantoins or carbamoylamino compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES547004A 1984-09-17 1985-09-16 Un procedimiento para preparar hidantoinas opticamente acti-vas Expired ES8701734A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59195392A JPS6172762A (ja) 1984-09-17 1984-09-17 光学活性ヒダントイン類の製造法

Publications (2)

Publication Number Publication Date
ES547004A0 true ES547004A0 (es) 1986-12-01
ES8701734A1 ES8701734A1 (es) 1986-12-01

Family

ID=16340383

Family Applications (4)

Application Number Title Priority Date Filing Date
ES547004A Expired ES8701734A1 (es) 1984-09-17 1985-09-16 Un procedimiento para preparar hidantoinas opticamente acti-vas
ES554323A Expired ES8706832A1 (es) 1984-09-17 1986-04-24 Un procedimiento para preparar hidantoinas opticamente activas
ES554324A Expired ES8706833A1 (es) 1984-09-17 1986-04-24 Un procedimiento para preparar un aminoacido opticamente activo
ES554322A Expired ES8706831A1 (es) 1984-09-17 1986-04-24 Un procedimiento para preparar un aminoacido opticamente activo

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES554323A Expired ES8706832A1 (es) 1984-09-17 1986-04-24 Un procedimiento para preparar hidantoinas opticamente activas
ES554324A Expired ES8706833A1 (es) 1984-09-17 1986-04-24 Un procedimiento para preparar un aminoacido opticamente activo
ES554322A Expired ES8706831A1 (es) 1984-09-17 1986-04-24 Un procedimiento para preparar un aminoacido opticamente activo

Country Status (6)

Country Link
US (1) US4812406A (es)
EP (1) EP0175312B1 (es)
JP (1) JPS6172762A (es)
CA (1) CA1318874C (es)
DE (1) DE3581248D1 (es)
ES (4) ES8701734A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190867A (en) * 1986-05-08 1993-03-02 Shell International Petroleum Company, Ltd. Process for the preparation of R-2,2-R1,R2 -1,3-dioxolane-4-methanol
EP0264586B1 (en) * 1986-08-28 1991-04-03 Sanwa Kagaku Kenkyusho Co., Ltd. Hydantoin derivatives for treating complications of diabetes
DE19524519B4 (de) * 1995-07-05 2004-10-14 Robert Bosch Gmbh Schneidwerk für Gartenhäcksler
JPH1072446A (ja) * 1996-06-24 1998-03-17 Sumitomo Chem Co Ltd 1−置換−ヒダントイン類の製造法
SE0100902D0 (sv) 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
CA2486350A1 (en) * 2002-06-05 2003-12-24 Kaneka Corporation Process for producing optically active .alpha.-methylcysteine derivative
SE0202539D0 (sv) 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
AU2003261774A1 (en) * 2002-09-06 2004-03-29 Kaneka Corporation PROCESS FOR PRODUCING L-Alpha-METHYLCYSTEINE DERIVATIVE
JPWO2004063385A1 (ja) * 2003-01-10 2006-05-18 株式会社カネカ 光学活性α−メチルシステイン誘導体の製造方法
US7648992B2 (en) 2004-07-05 2010-01-19 Astrazeneca Ab Hydantoin derivatives for the treatment of obstructive airway diseases
SE0401762D0 (sv) 2004-07-05 2004-07-05 Astrazeneca Ab Novel compounds
SE0403086D0 (sv) 2004-12-17 2004-12-17 Astrazeneca Ab Compounds
SE0403085D0 (sv) 2004-12-17 2004-12-17 Astrazeneca Ab Novel componds
TW200800954A (en) * 2006-03-16 2008-01-01 Astrazeneca Ab Novel crystal modifications
TW200831488A (en) 2006-11-29 2008-08-01 Astrazeneca Ab Novel compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT987278B (it) * 1973-05-11 1975-02-20 Snam Progetti Procedimento per la preparazione di l carbamil ammino acidi e dei corrispondenti l amminoacidi
IT1046399B (it) * 1975-05-12 1980-06-30 Snam Progetti Procedimento per la preparazione di d carbamil amminoacidi e dei corrispondenti d amminoacidi
JPS5391189A (en) * 1976-12-30 1978-08-10 Kanegafuchi Chem Ind Co Ltd Preparation of d-n-carbamoyl-alpha-amino acids
IT1109506B (it) * 1978-05-23 1985-12-16 Snam Progetti Processo enzimatico-microbiologico per la produzione di amminoacidi otticamente attivi a partire da idantoine e/o carbamil-derivati racemi
US4286098A (en) * 1980-03-28 1981-08-25 Pfizer Inc. Process for the preparation of chiral hydantoins
DE3031151A1 (de) * 1980-08-18 1982-04-15 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von d-n-carbamoyl-(alpha)-aminosaeuren und mikroorganismen dafuer
IT1209495B (it) * 1984-02-02 1989-08-30 A San Donato Milanese Milano Procedimento per la preparazione di l-alfa-amminoacidi.

Also Published As

Publication number Publication date
EP0175312B1 (en) 1991-01-09
ES8706832A1 (es) 1987-07-01
US4812406A (en) 1989-03-14
ES554322A0 (es) 1987-07-01
EP0175312A3 (en) 1987-04-29
ES554323A0 (es) 1987-07-01
JPH0239B2 (es) 1990-01-05
JPS6172762A (ja) 1986-04-14
CA1318874C (en) 1993-06-08
ES554324A0 (es) 1987-07-01
ES8706833A1 (es) 1987-07-01
ES8701734A1 (es) 1986-12-01
DE3581248D1 (de) 1991-02-14
ES8706831A1 (es) 1987-07-01
EP0175312A2 (en) 1986-03-26

Similar Documents

Publication Publication Date Title
ES548135A0 (es) Un procedimiento para preparar dioxafosforinanos
ES551517A0 (es) Un procedimiento para preparar aril-hidroxamatos
ES542311A0 (es) Procedimiento para preparar un polipeptido
ES543257A0 (es) Procedimiento para preparar un polipeptido
ES543047A0 (es) Un procedimiento para preparar un derivado de pirimidina
ES545386A0 (es) Un procedimiento para preparar un organotitanato
ES547004A0 (es) Un procedimiento para preparar hidantoinas opticamente acti-vas
ES549860A0 (es) Un procedimiento para preparar aminoacil-ladanos
ES543929A0 (es) Un procedimiento para preparar un p-isononanoiloxibenceno- sulfonato
MX164160B (es) Un procedimiento para preparar un compuesto neoalcoxi
ES546157A0 (es) Un procedimiento para preparar quinolonas
ES550002A0 (es) Un procedimiento para preparar un poliuretano
ES542149A0 (es) Un procedimiento para preparar hidroxi-4-2h-1-benzotiopiran-2-onas
ES544863A0 (es) Un procedimiento para preparar un compuesto de beta-lactama
ES544864A0 (es) Un procedimiento para preparar 4-acetoxi-3-hidroxietilazeti-zin-2-ona
ES531550A0 (es) Procedimiento para preparar un fenilaminobencoalcanol
ES540784A0 (es) Un procedimiento para preparar compuestos relacionados con espergualina
ES545894A0 (es) Un procedimiento para preparar un derivado de 3-carbonil-1- aminoalquil-1h-indol
ES545111A0 (es) Un procedimiento para preparar un derivado de fluoralilamina
ES552138A0 (es) Un procedimiento para preparar poliarilen-polieteres
ES544381A0 (es) Un procedimiento para preparar 5-desoxi-l-arabinosa
ES547222A0 (es) Un procedimiento para preparar un polimero termoendurecible
ES553983A0 (es) Un procedimiento para preparar compuestos de piridobenzodiazepina
ES546669A0 (es) Un procedimiento para preparar compuestos relacionados con histargina
ES541321A0 (es) Procedimiento para preparar un derivado de fenotiazina